ROSENOW EDWARD C III 4
4 · BIOSANTE PHARMACEUTICALS INC · Filed Feb 2, 2009
Insider Transaction Report
Form 4
ROSENOW EDWARD C III
Director
Transactions
- Award
Non-Statutory Stock Option (right to buy)
2009-02-02+50,000→ 50,000 totalExercise: $1.51From: 2010-02-02Exp: 2019-02-01→ Common Stock (50,000 underlying)
Holdings
- 17,540
Common Stock